A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates

$ 18.50

4.6 (272) In stock

MASH CALL for Fast and Reliable Identification and Comparison of Drug Candidates - InSphero

2023-5892

Inflammatory environment induced in 3D liver NASH model (A) Time course

A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates

Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists

Set-up of human liver primary coculture in a 3D environment (A) Real

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Reduced hepatic inflammation following combined treatment with OCA and

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). - Abstract - Europe PMC

Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis - ScienceDirect

Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells